Daniel S. Loeb - 13 Jun 2022 Form 4 Insider Report for SentinelOne, Inc. (S)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Jun 2022, 18:28:43 UTC
Prior SEC filing
20 May 2022
Next SEC filing
21 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
DANIEL S. LOEB, /s/ William Song, as Attorney-in-Fact for Daniel S. Loeb

Key filing fact

Daniel S. Loeb filed Form 4 for SentinelOne, Inc. (S) on 15 Jun 2022.

Key facts

  • This page summarizes Daniel S. Loeb's Form 4 filing for SentinelOne, Inc. (S).
  • 7 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Jun 2022, 18:28.

Change

  • Previous filing in this sequence was filed on 20 May 2022.
  • Current net transaction value: -$53,506,732.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

S transaction

Class A common stock, par value $0.0001 per share

Sale

Transaction value
$19,891,780
Shares
-963,651
Change %
-29%
Price
$20.64
Shares after
2,324,924
Date
13 Jun 2022
Ownership
See footnotes
Footnotes
F1, F2, F3
S transaction

Class A common stock, par value $0.0001 per share

Sale

Transaction value
$773,150
Shares
-36,349
Change %
-1.6%
Price
$21.27
Shares after
2,288,575
Date
13 Jun 2022
Ownership
See footnotes
Footnotes
F1, F2, F4
S transaction

Class A common stock, par value $0.0001 per share

Sale

Transaction value
$7,179,108
Shares
-327,677
Change %
-14%
Price
$21.91
Shares after
1,960,898
Date
14 Jun 2022
Ownership
See footnotes
Footnotes
F1, F2, F5
S transaction

Class A common stock, par value $0.0001 per share

Conversion of derivative security

Transaction value
Shares
+500,000
Change %
+25%
Price
Shares after
2,460,898
Date
15 Jun 2022
Ownership
See footnotes
Footnotes
F1, F2
S transaction

Class A common stock, par value $0.0001 per share

Sale

Transaction value
$14,110,510
Shares
-639,857
Change %
-26%
Price
$22.05
Shares after
1,821,041
Date
15 Jun 2022
Ownership
See footnotes
Footnotes
F1, F2, F6
S transaction

Class A common stock, par value $0.0001 per share

Sale

Transaction value
$11,552,183
Shares
-511,102
Change %
-28%
Price
$22.60
Shares after
1,309,939
Date
15 Jun 2022
Ownership
See footnotes
Footnotes
F1, F2, F7

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

S transaction Derivative

Class B Common Stock, par value $0.0001 per share

Conversion of derivative security

Transaction value
$0
Shares
-500,000
Change %
-2.3%
Price
$0.000000
Shares after
21,018,907
Date
15 Jun 2022
Ownership
See footnotes
Underlying class
Class A common stock, par value $0.0001 per share
Underlying amount
500,000
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

See Exhibit 99.1

Footnote F2

See Exhibit 99.1

Footnote F3

See Exhibit 99.1

Footnote F4

See Exhibit 99.1

Footnote F5

See Exhibit 99.1

Footnote F6

See Exhibit 99.1

Footnote F7

See Exhibit 99.1

SEC remarks

The Power of Attorney granted by Daniel S. Loeb in favor of William Song and Joshua L. Targoff, dated February 17, 2021, was previously filed with the SEC on March 4, 2021 as Exhibit 24 to the Form 4 filed by Third Point LLC and Daniel S. Loeb with respect to Radius Global Infrastructure, Inc. and is incorporated herein by reference.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .